GLYC logo

GlycoMimetics Inc

GLYC

$3.01

+ $0.07 (2.38%) This month

Closed: 1 Mar 2024 21:00 US/Eastern

Key details

CEO

Rachel King

Employees

54

Headquarters

Rockville, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About GlycoMimetics Inc

at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG